Pulmonary Growth Abnormalities as Etiologies for Pediatric Pulmonary Hypertension.

Diseases leading to diffuse lung disease (DLD) or interstitial lung disease in infants and young children, also designated in the literature by the acronym chILD, are heterogeneous and have been a challenge to clinicians for decades in terms of both diagnosis and treatment. This article is protected by copyright. All rights reserved.